Infections, Pandemics, and Sleep Disorders

• Published in: Neuroscience and behavioral physiology Vol. 52; no. 3; pp. 319 - 325
• Main Authors: Kolokolov, O. V., Salina, E. A., Yudina, V. V., Shuldyakov, A. A., Runnova, A. E.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 2022; Springer Nature B.V
• Subjects: Behavioral Sciences; Biomedical and Life Sciences; Biomedicine; Coronaviruses; COVID-19; Immune system; Infectious diseases; Neurobiology; Neurological diseases; Neurosciences; Pandemics; Sleep; Sleep disorders; COVID-19; anxiety; sleep impairments; infection; SARS-CoV-2; sleeplessness; depression; melatonin; Sonnovan; pandemics
• ISSN: 0097-0549; 1573-899X
• DOI: 10.1007/s11055-022-01242-2

Studies of the neurological symptoms and signs associated with the acute and late phases of infectious diseases are important in pandemic conditions. The novel coronavirus infection (COVID-19) pandemic has increased the number of patients with sleeplessness, this being an adverse prognostic factor for infections. This review addresses the factors and mechanisms of sleep impairments and their relationship with inflammation and immune system dysfunction in infectious diseases. In particular, impairments to the functioning of the melatoninergic system are discussed as the cause of sleeplessness during pandemics. The relevance of developing measures for rehabilitating patients, particularly use of Sonnovan to restore normal sleep, which plays a fundamental role in supporting people’s mental and physical health, is emphasized.